Credit Industriel ET Commercial Takes $4.10 Million Position in Masimo Corporation $MASI

Credit Industriel ET Commercial purchased a new position in shares of Masimo Corporation (NASDAQ:MASI) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 23,050 shares of the medical equipment provider’s stock, valued at approximately $4,100,000.

A number of other institutional investors and hedge funds have also bought and sold shares of MASI. Global Retirement Partners LLC acquired a new position in Masimo during the 4th quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Masimo in the fourth quarter valued at about $28,000. Los Angeles Capital Management LLC bought a new position in shares of Masimo during the fourth quarter worth about $31,000. Rothschild Investment LLC raised its position in shares of Masimo by 12,950.0% during the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 259 shares during the last quarter. Finally, Torren Management LLC acquired a new position in shares of Masimo in the fourth quarter worth approximately $35,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Stock Performance

Shares of Masimo stock opened at $179.95 on Tuesday. The stock has a market capitalization of $9.42 billion, a PE ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.99. The stock has a 50 day moving average price of $179.17 and a two-hundred day moving average price of $165.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MASI. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Nine investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Masimo has an average rating of “Hold” and a consensus price target of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.